Cancer doctors are lobbying for changes to House-passed drug pricing legislation after an Avalere Health study found the bill would cut an average 40% off the Medicare add-on payment to doctors for administering drugs that are subject to negotiation.
Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.
Log in to access this content.
Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.
© 2002-2021. Inside Washington Publishers | Contact Us